位于腹前脑部的诺拉基上腺素对于阿片类药物戒断引起的厌恶至关重要
1University of Pennsylvania School of Medicine, Department of Psychiatry, VA Medical Center, Philadelphia 19104, USA.
Nature
|February 10, 2000
概括
吸食阿片类药物的戒断是由于诺亚上腺素而引起的厌恶. 针对特定的大脑路径,特别是结节 (BNST) 的床核,可以减少这种厌恶,为成治疗提供新的见解.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成研究 研究成研究
背景情况:
- 慢性阿片类药物滥用导致严重的厌恶性戒断综合征.
- 大脑中的诺拉丁上腺素与阿片类药物戒断有关,但具体系统尚不清楚.
研究的目的:
- 确定参与阿片类药物戒断的厌恶性质的特定诺亚上腺系统.
- 为了研究结核 (BNST) 床核在调解阿片类药物戒断厌恶中的作用.
主要方法:
- 在老鼠的BNST中微注射诺亚类受体对抗剂和激动剂.
- 免疫组织化学分析以识别激活的诺亚上腺细胞群.
- 针对特定的诺亚上腺素路径的损伤研究,包括髓突出和骨干部位.
主要成果:
- 在BNST中的β-noradrenergic受体对抗剂和α2-受体激动剂减弱的阿片类戒断诱导的条件地方厌恶.
- 在尾髓的A1和A2北腺细胞组中的BNST投射细胞在撤回期间被激活.
- 损伤性髓突出减少了厌恶,而状骨损伤没有影响.
结论:
- 从尾骨中向BNST输入的诺拉基因输入对于阿片类药物戒断的厌恶性至关重要.
- 这一途径代表了缓解阿片类戒断症状和减少复发的潜在治疗目标.
相关概念视频
Adrenergic Neurons: Neurotransmission
5.4K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.4K
Adrenergic Agonists: Therapeutic Uses
2.0K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Drug Abuse and Addiction: Pharmacological Phenomena
1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
Analgesia and Pain Management
3.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K


